Kardigan, Inc. (KARD) Live Share Price, Invest From India

Kardigan, Inc. Stock Performance

as on September 15, 2026 at 2:15 pm IST

Day's Low
Day's High
$17.81
Day's Price Range
$19.37
$19.05
6.51%
Downside
1.68%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$19.05
100.00%
Downside
-100.00%
Upside

Kardigan, Inc. share price movements today

Previous Close: $18.52
Open: $18.59
Volume: 575.5K
Market Cap: $1.7B
Day's Low - High: $17.81 - $19.37

Kardigan, Inc. Historical Returns

1 Month Return: -5.69 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Kardigan, Inc. Stock Fundamentals & Key Indicators

Check Kardigan, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-2.14

Dividend Yield

0.00%

PE Ratio (TTM)

-8.65

Industry PE ratio

-6.33

PEG Ratio

-0.08654205607476635

Return On Equity TTM

-109.44%

Kardigan, Inc. Stock Valuation

Track how Kardigan, Inc. P/E has moved over time to understand its valuation trends.

Kardigan, Inc. in the last 1 year

Overview
Trends

Lowest (-6.88x)

December 31, 2025

Today (-6.88x)

December 31, 2025

Industry (-6.33x)

December 31, 2025

Highest (-6.88x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -6.88x

Kardigan, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kardigan, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kardigan, Inc.	StrongBuy	$1.7B	NA	-8.65	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$130.6B	175.08%	29.76	86.04%	NA
Moderna	BUY	$57.5B	-66.24%	-18.04	-12.57%	NA
Regeneron	BUY	$80.5B	21.74%	18.95	84.86%	47.339999999999996%

Analyst Recommendation on Kardigan, Inc. Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Kardigan, Inc.. Average target price of $42.25

Indian Investors' Interest in Kardigan, Inc. Stock

Search interest for Kardigan, Inc. Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 16, 2026 to September 15, 2026

Change:74% versus previous 30 day period

Kardigan, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2026	Jun 2026
Total Revenue	-	-
Gross Profit	-	-2
Operating Income	-58	-75
EBITDA	-56	-73
Interest Expense	-	-
Depreciation	2	2
Income Before Tax	-56	-116
Income Tax Expense	-	-
Net Income	-56	-116
Net Profit Margin	0.00%	0.00%

Kardigan, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	-
Operating Income	-201
EBITDA	-195
Interest Expense	-
Depreciation	5
Income Before Tax	-196
Income Tax Expense	-4
Net Income	-191
Net Profit Margin	0.00%

Kardigan, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026	Jun 2026
Net Income	-56	-116
Operating Cash Flow	-56	-50
Investing Cash Flow	19	-73
Financing Cash Flow	10	426
Change in Cash	-27	302

Kardigan, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-191
Operating Cash Flow	-151
Investing Cash Flow	-237
Financing Cash Flow	447
Change in Cash	59

Global Institutional Holdings in Kardigan, Inc.

Funds	Holdings
Joseph Edelman	8.77%
Michael Rockefeller	0.44%
Richard Driehaus	0.21%
Vanguard	0.16%
Goldman Sachs	0.04%

See all

Insights on Kardigan, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, KARD stock has moved down by -11.8%

About Kardigan, Inc.

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The company incorporates Prolaio's cardiovascular data collection and analytics platform, which includes FDA-cleared algorithms and high-density patient data, to support drug development and clinical intelligence. The company engages in strategic in-licensing and acquisitions to expand its pipeline of targeted treatments. Kardigan serves biopharmaceutical companies, cardiovascular researchers, and healthcare providers in the cardiology sector. The company was formerly known as EnCarda, Inc. and changed its name to Kardigan, Inc. in December 2024. The company was founded in 2023 and is based in Princeton, New Jersey.

Organisation	Kardigan, Inc.
Headquarters	506 Carnegie Center Drive, Princeton, NJ, United States, 08540
Industry	Biotechnology
CEO	Mr. Tassos Anastasios E. Gianakakos M.Sc., MBA
E-voting on shares	Click here to vote

Key Management of Kardigan, Inc.

Name	Title
Dr. Bob McDowell Ph.D.	Co-founder & Scientific Advisor
Dr. Leslie A. Leinwand Ph.D.	Co-Founder
Dr. Elizabeth McNally M.D., Ph.D.	Co-Founder
Mr. Clayton Robertson	Vice President of Investor Relations
Ms. Emily Faucette	Chief Communications Officer
Mr. Tassos Anastasios E. Gianakakos M.Sc., MBA	Co-Founder, President, CEO & Chairman
Dr. Jay Edelberg M.D., Ph.D.	Co-founder & Chief Medical Officer
Mr. John B. Moriarty Jr., ESQ., J.D.	Chief Legal Officer & Corporate Secretary
Ms. Brianne Puglisi	Chief Financial Officer
Mr. Donald Mackenzie Ph.D.	Chief Technical Operations Officer

FAQs

What is Kardigan, Inc. share price today?

Kardigan, Inc. share price today is $19.05 as on September 15, 2026 at 8:45 am IST at the close of the market. Kardigan, Inc. share today touched a day high of $19.37 and a low of $17.81.

What is the 52 week high and 52 week low for Kardigan, Inc. share?

Kardigan, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Kardigan, Inc. stock price today i.e. September 15, 2026 at 8:45 am IST is closed at $19.05,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kardigan, Inc.'s market capitalisation today?

Kardigan, Inc. market capitalisation is $0.00T as on September 15, 2026 at 8:45 am IST.

How to invest in Kardigan, Inc. Stock (KARD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kardigan, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kardigan, Inc. Shares that will get you 0.0787 shares as per Kardigan, Inc. share price of $19.05 per share as on September 15, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kardigan, Inc. Stock (KARD) from India?

Indian investors can start investing in Kardigan, Inc. (KARD) shares with as little as ₹95.54 or $1 (as of September 15, 2026 at 4:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Kardigan, Inc. stock (as per the Rupee-Dollar exchange rate as on September 15, 2026 at 4:41 pm IST). Based on Kardigan, Inc. share’s latest price of $19.05 as on September 15, 2026 at 8:45 am IST, you will get 0.5249 shares of Kardigan, Inc.. Learn more about fractional shares .